Startseite>>Signaling Pathways>> Others>>Antitumor Compound 1

Antitumor Compound 1

Katalog-Nr.GC35363

Antitumorverbindung 1 ist eine wirksame Verbindung, die ein neues Imidazopyridin mit ausgezeichneter AntitumoraktivitÄt als Wirkstoff umfasst.

Products are for research use only. Not for human use. We do not sell to patients.

Antitumor Compound 1 Chemische Struktur

Cas No.: 420126-30-3

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
306,00 $
Auf Lager
2mg
216,00 $
Auf Lager
5mg
324,00 $
Auf Lager
10mg
464,00 $
Auf Lager
50mg
1.391,00 $
Auf Lager
100mg
1.947,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Antitumor Compound 1 is a potent compound which comprises a new imidazopyridine having excellent antitumor activity as an active ingredient.Reference:Polymer-linked imidazopyridines useful as tumor-targeting cytotoxic agentsBy Kasuya, Hiroshi; Miyazaki, Hideki; Hayakawa, Ichio; Kanno, Yuichi; Watanabe, KazuyoshiFrom Jpn. Kokai Tokkyo Koho (2004), JP 2004002826 A 20040108. Pharmaceuticals containing imidazopyridines for prophylactic and therapeutic treatment of tumorBy Hayakawa, Ichio; Kanno, Yuichi; Azuma, Toshiki; Furukawa, Hidehiko; Naruto, Shunji; Kurakata, ShinichiFrom Jpn. Kokai Tokkyo Koho (2003), JP 2003313126A 20031106.Preparation of imidazopyridine derivatives as antitumor agentsBy Hayakawa, Ichiro; Sugano, Yuichi; Agatsuma, Toshinori; Furukawa, Hidehiko; Kurakata, Shinichi; Naruto, ShunjiFrom PCT Int. Appl. (2002), WO 2002034748 A1 20020502.

Bewertungen

Review for Antitumor Compound 1

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Antitumor Compound 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.